Intravascular Imaging: a Glacovian appraisal of the ABSORB II trial

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Professor Patrick Serruys gives a comprehensive and unique insight into some of the intracoronary imaging results seen in an ABSORB-II substudy


  • Objective: to confirm that Absorb bioresorbable scaffold has more potential to exhibit vessel remodeling than Xience metallic stents
  • Overview of factors predicting expansive remodelling in arteries, treated either with Absorb or Xience
  • Lesions treated with Absorb exhibited frequently larger increase in mean vessel area and lumen area than lesions treated with Xience
  • Absorb implantation, female gender, expected balloon-artery ratio ≥ 1.25, expansion index ≥ 0.8, previous PCI, and higher mean level of LDL cholesterol (average over 3 years) were independent factors predicting expansive remodeling.


Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Learning Objectives

We know that sometimes IVUS appears difficult to understand and look forward to making things Simple for you.

Including:

  • International faculty
  • Hands on experience (break-out sessions:
    • Assembling the kit
    • Making Measurements (iPad/computer)
    • Case practice with instructor support
  • Latest clinical evidence
  • Structured case-based lectures on identification of thrombus, dissection, malapposition and more
  • Live case demonstrations using IVUS co-registration
Loading Simple Education